VUB spin-off Lavima Fertility develops novel fertility treatment that reduces risks and burden

Couples unable to get pregnant naturally often resort to In Vitro Fertilisation (IVF) to fulfil their desire to have children. To obtain mature eggs for IVF, women typically undergo ovarian stimulation with hormones which can be very burdensome. A team of scientists of the Follicle Biology (FOBI) Research Laboratory at the Vrije Universiteit Brussel (VUB) in collaboration with the UZ Brussel fertility clinic has succeeded in developing a novel method for In Vitro Maturation (IVM) of oocytes, called CAPA-IVM. This is a method allowing a mild and low-burden fertility treatment for subfertile patients. To bring the technique to the patient, Lavima Fertility, a spin-off company of the VUB and UZ Brussel, was created.
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.